Hoffmann Green Cement Technologies Societe anonyme Valuation
Is 0VW undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0VW when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0VW (€4.34) is trading below our estimate of fair value (€59.26)
Significantly Below Fair Value: 0VW is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0VW?
Key metric: As 0VW is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 0VW's PS Ratio? | |
|---|---|
| PS Ratio | 9.6x |
| Sales | €7.65m |
| Market Cap | €73.17m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 11.4x |
| Enterprise Value/EBITDA | -15.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 0VW's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.7x | ||
STO3 Sto SE KGaA | 0.4x | 1.8% | €706.9m |
BNN BRAIN Biotech | 1.2x | 8.5% | €69.9m |
IBU IBU-tec advanced materials | 0.6x | 19.2% | €27.4m |
NTG Nabaltec | 0.6x | 5.0% | €122.3m |
0VW Hoffmann Green Cement Technologies Societe anonyme | 9.6x | 81.9% | €73.2m |
Price-To-Sales vs Peers: 0VW is expensive based on its Price-To-Sales Ratio (9.6x) compared to the peer average (0.7x).
Price to Sales Ratio vs Industry
How does 0VW's PS Ratio compare vs other companies in the European Basic Materials Industry?
| 0 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Sales vs Industry: 0VW is expensive based on its Price-To-Sales Ratio (9.6x) compared to the European Basic Materials industry average (1x).
Price to Sales Ratio vs Fair Ratio
What is 0VW's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 9.6x |
| Fair PS Ratio | 10.1x |
Price-To-Sales vs Fair Ratio: 0VW is good value based on its Price-To-Sales Ratio (9.6x) compared to the estimated Fair Price-To-Sales Ratio (10.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €4.34 | €15.60 +259.4% | 20.2% | €20.00 | €12.80 | n/a | 3 |
| Nov ’25 | €4.93 | €15.60 +216.4% | 20.2% | €20.00 | €12.80 | n/a | 3 |
| Oct ’25 | €7.06 | €15.60 +121.0% | 20.2% | €20.00 | €12.80 | n/a | 3 |
| Sep ’25 | €9.14 | €15.83 +73.2% | 18.7% | €20.00 | €13.50 | n/a | 3 |
| Aug ’25 | €9.82 | €15.83 +61.2% | 18.7% | €20.00 | €13.50 | n/a | 3 |
| Jul ’25 | €9.52 | €15.83 +66.3% | 18.7% | €20.00 | €13.50 | n/a | 3 |
| Jun ’25 | €11.35 | €17.00 +49.8% | 17.6% | €20.00 | €14.00 | n/a | 2 |
| May ’25 | €11.20 | €15.83 +41.4% | 18.7% | €20.00 | €13.50 | n/a | 3 |
| Apr ’25 | €11.16 | €15.83 +41.9% | 18.7% | €20.00 | €13.50 | n/a | 3 |
| Mar ’25 | €9.15 | €17.00 +85.8% | 17.6% | €20.00 | €14.00 | n/a | 2 |
| Feb ’25 | €9.66 | €15.83 +63.9% | 18.7% | €20.00 | €13.50 | n/a | 3 |
| Jan ’25 | €8.05 | €15.83 +96.7% | 18.7% | €20.00 | €13.50 | n/a | 3 |
| Dec ’24 | €7.71 | €15.83 +105.4% | 18.7% | €20.00 | €13.50 | n/a | 3 |
| Nov ’24 | €7.42 | €15.83 +113.4% | 18.7% | €20.00 | €13.50 | €4.93 | 3 |
| Oct ’24 | €7.51 | €15.83 +110.8% | 18.7% | €20.00 | €13.50 | €7.06 | 3 |
| Sep ’24 | €8.79 | €15.83 +80.1% | 18.7% | €20.00 | €13.50 | €9.14 | 3 |
| Aug ’24 | €9.03 | €15.83 +75.3% | 18.7% | €20.00 | €13.50 | €9.82 | 3 |
| Jul ’24 | €10.22 | €15.83 +54.9% | 18.7% | €20.00 | €13.50 | €9.52 | 3 |
| Jun ’24 | €10.18 | €15.83 +55.5% | 18.7% | €20.00 | €13.50 | €11.35 | 3 |
| May ’24 | €9.10 | €15.83 +74.0% | 18.7% | €20.00 | €13.50 | €11.20 | 3 |
| Apr ’24 | €7.39 | €16.50 +123.3% | 23.6% | €22.00 | €13.50 | €11.16 | 3 |
| Mar ’24 | €9.33 | €17.67 +89.4% | 18.7% | €22.00 | €14.00 | €9.15 | 3 |
| Feb ’24 | €10.08 | €17.67 +75.3% | 18.7% | €22.00 | €14.00 | €9.66 | 3 |
| Jan ’24 | €10.28 | €17.67 +71.9% | 18.7% | €22.00 | €14.00 | €8.05 | 3 |
| Dec ’23 | €9.08 | €17.67 +94.6% | 18.7% | €22.00 | €14.00 | €7.71 | 3 |
| Nov ’23 | €8.47 | €17.67 +108.6% | 18.7% | €22.00 | €14.00 | €7.42 | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Arkema
€5.7b
Manufactures and sells specialty chemicals and advanced materials worldwide.
V1S
€74.85
7D
0.4%
1Y
-19.9%
Minerals Technologies
US$2.6b
Develops, produces, and markets various mineral, mineral-based, and related systems and services.
MNK
US$74.50
7D
1.4%
1Y
33.0%
Cabka
€60.3m
Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.
7GW
€2.38
7D
-7.8%
1Y
-61.1%